{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:08:19Z","timestamp":1790262499758,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14128-2","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:59:09Z","timestamp":1785841149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative clinical outcomes of pandrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae infections in children"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-979X","authenticated-orcid":false,"given":"\u0130rem Ceren","family":"Erba\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eilem \u00d6zdem","family":"Alata\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe \u00c7ak\u0131l","family":"G\u00fczin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Karao\u011flu","family":"Asrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ala\u00e7am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fen Hazal","family":"Buran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Cem","family":"Ergon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur\u015fen","family":"Belet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"10325","key":"14128_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"14128_CR2","doi-asserted-by":"publisher","first-page":"4065603","DOI":"10.1155\/2016\/4065603","volume":"2016","author":"S Basak","year":"2016","unstructured":"Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathog. 2016;2016:4065603. https:\/\/doi.org\/10.1155\/2016\/4065603.","journal-title":"J Pathog"},{"key":"14128_CR3","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report. https:\/\/www.who.int\/publications\/i\/item\/9789240027336. Accessed 9 June 2024."},{"issue":"10","key":"14128_CR4","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1080\/21645515.2021.1927412","volume":"17","author":"N Mat Rahim","year":"2021","unstructured":"Mat Rahim N, Lee H, Strych U, AbuBakar S. Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development. Hum Vaccin Immunother. 2021;17(10):3784\u201394. https:\/\/doi.org\/10.1080\/21645515.2021.1927412.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"14128_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/antibiotics9030119","volume":"9","author":"C Ayoub Moubareck","year":"2020","unstructured":"Ayoub Moubareck C, Hammoudi HD. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics. 2020;9(3):119. https:\/\/doi.org\/10.3390\/antibiotics9030119.","journal-title":"Antibiotics"},{"issue":"3","key":"14128_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5001\/omj.2019.37","volume":"34","author":"G Asokan","year":"2019","unstructured":"Asokan G, Ramadhan T, Ahmed E, Sanad H. WHO global priority pathogens list: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J. 2019;34(3):184\u201393. https:\/\/doi.org\/10.5001\/omj.2019.37.","journal-title":"Oman Med J"},{"issue":"1","key":"14128_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13756-023-01343-8","volume":"29","author":"R Itani","year":"2023","unstructured":"Itani R, Khojah HMJ, Karout S, et al. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob Resist Infect Control. 2023;29(1):136. https:\/\/doi.org\/10.1186\/s13756-023-01343-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"14128_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/vaccines9060570","volume":"9","author":"C Ma","year":"2021","unstructured":"Ma C, McClean S. Mapping global prevalence of Acinetobacter baumannii and recent vaccine development to tackle it. Vaccines (Basel). 2021;9(6):570. https:\/\/doi.org\/10.3390\/vaccines9060570.","journal-title":"Vaccines (Basel)"},{"key":"14128_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12866-026-04727-z","volume":"26","author":"S Mermer","year":"2026","unstructured":"Mermer S, \u00c7a\u011flayan E. Prevalence, clinical characteristics, and antibiotic resistance of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in T\u00fcrkiye (2023\u20132025). BMC Microbiol. 2026;26:114. https:\/\/doi.org\/10.1186\/s12866-026-04727-z.","journal-title":"BMC Microbiol"},{"issue":"6","key":"14128_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1089\/mdr.2022.0247","volume":"29","author":"M Havan","year":"2023","unstructured":"Havan M, Kendirli T, Parlar \u00d6T, et al. Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella pneumoniae Infection in the Pediatric Intensive Care Unit. Microb Drug Resist. 2023;29(6):256\u201362. https:\/\/doi.org\/10.1089\/mdr.2022.0247.","journal-title":"Microb Drug Resist"},{"issue":"3","key":"14128_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10096-009-0857-7","volume":"29","author":"C Tsioutis","year":"2010","unstructured":"Tsioutis C, Kritsotakis EI, Maraki S, Gikas A. Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients. Eur J Clin Microbiol Infect Dis. 2010;29(3):301\u20135. https:\/\/doi.org\/10.1007\/s10096-009-0857-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"14128_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/1469-0691.12338","volume":"20","author":"AC Cicek","year":"2014","unstructured":"Cicek AC, Saral A, Iraz M, et al. OXA- and GES-type \u03b2-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20(5):410\u20135. https:\/\/doi.org\/10.1111\/1469-0691.12338.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"14128_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jhin.2013.03.002","volume":"84","author":"E Alp","year":"2013","unstructured":"Alp E, Per\u00e7in D, Colako\u011flu S, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect. 2013;84(2):178\u201380. https:\/\/doi.org\/10.1016\/j.jhin.2013.03.002.","journal-title":"J Hosp Infect"},{"key":"14128_CR14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. https:\/\/www.eucast.org. Accessed January 1, 2024."},{"issue":"3","key":"14128_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"14128_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1\u201345. https:\/\/doi.org\/10.1086\/599376.","journal-title":"Clin Infect Dis"},{"key":"14128_CR17","unstructured":"Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN). Patient Safety Component Manual. Chapter 6: Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event. Available at: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf. Accessed June 8, 2026."},{"key":"14128_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002.","journal-title":"Am J Infect Control"},{"issue":"1","key":"14128_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12879-023-08563-8","volume":"5","author":"TA Hafiz","year":"2023","unstructured":"Hafiz TA, Alanazi S, Alghamdi SS, et al. Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia. BMC Infect Dis. 2023;5(1):579. https:\/\/doi.org\/10.1186\/s12879-023-08563-8.","journal-title":"BMC Infect Dis"},{"key":"14128_CR20","doi-asserted-by":"publisher","unstructured":"Castillo Bejarano JI, Llaca D\u00edaz J, e la O Cavazos ME, et al. Carbapenem-resistant Acinetobacter baumannii infection in children from a third-level hospital in Mexico: clinical characteristics and molecular epidemiology. J Pediatric Infect Dis Soc. 2023;31;12(7):431\u2013435. https:\/\/doi.org\/10.1093\/jpids\/piad046.","DOI":"10.1093\/jpids\/piad046"},{"issue":"10","key":"14128_CR21","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s10096-025-05216-3","volume":"44","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou H, Zhao J, et al. High co-infection burden and ICU-specific pathogen profiles in pediatric Candida albicans respiratory infections: a large-scale tNGS analysis. Eur J Clin Microbiol Infect Dis. 2025;44(10):2495\u2013508. https:\/\/doi.org\/10.1007\/s10096-025-05216-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"14128_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/mmy\/myw009","volume":"54","author":"X Tan","year":"2016","unstructured":"Tan X, Zhu S, Yan D, et al. Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol. 2016;54(6):557\u201366. https:\/\/doi.org\/10.1093\/mmy\/myw009.","journal-title":"Med Mycol"},{"key":"14128_CR23","doi-asserted-by":"publisher","first-page":"1545999","DOI":"10.3389\/fcimb.2025.1545999","volume":"15","author":"X Ran","year":"2025","unstructured":"Ran X, Chen X, Wang C, et al. Carbapenem-resistant Klebsiella pneumoniae infections in Chinese children: in vitro activities of ceftazidime-avibactam and aztreonam-avibactam against carbapenemase-producing strains in a two-center study. Front Cell Infect Microbiol. 2025;15:1545999. https:\/\/doi.org\/10.3389\/fcimb.2025.1545999.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"14128_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21608\/MID.2021.70493.1139","volume":"2","author":"R Aamir","year":"2021","unstructured":"Aamir R, Ateya RM, Arafa M, Yahia S. Ceftazidime\/avibactam efficiency tested in vitro against carbapenem-resistant Klebsiella pneumoniae isolated from neonates with sepsis. Microbes Infect Dis. 2021;2(3):529\u201340. https:\/\/doi.org\/10.21608\/MID.2021.70493.1139.","journal-title":"Microbes Infect Dis"},{"issue":"6","key":"14128_CR25","doi-asserted-by":"publisher","first-page":"107163","DOI":"10.1016\/j.ijantimicag.2024.107163","volume":"63","author":"J Zhou","year":"2024","unstructured":"Zhou J, Yan G, Tang C, et al. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient. Int J Antimicrob Agents. 2024;63(6):107163. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107163.","journal-title":"Int J Antimicrob Agents"},{"issue":"5\u20136","key":"14128_CR26","doi-asserted-by":"publisher","first-page":"106679","DOI":"10.1016\/j.ijantimicag.2022.106679","volume":"60","author":"YL Lee","year":"2022","unstructured":"Lee YL, Ko WC, Hsueh PR. Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime\/avibactam, meropenem\/vaborbactam, and comparators against these isolates: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. Int J Antimicrob Agents. 2022;60(5\u20136):106679. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106679.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"14128_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/antibiotics14111085","volume":"14","author":"A Yanik","year":"2025","unstructured":"Yanik A, Karasahin O. Ceftazidime-avibactam resistance in carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors and clinical outcomes. Antibiot (Basel). 2025;14(11):1085. https:\/\/doi.org\/10.3390\/antibiotics14111085.","journal-title":"Antibiot (Basel)"},{"key":"14128_CR28","doi-asserted-by":"publisher","unstructured":"Ko\u00e7er I, Demirbakan H. Assessment of carbapenemase genes and antibiotic resistance profiles in ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates: a single-center cross-sectional study. Medicine (Baltimore). 2025;104(41). https:\/\/doi.org\/10.1097\/MD.0000000000045289.","DOI":"10.1097\/MD.0000000000045289"},{"issue":"5","key":"14128_CR29","first-page":"569","volume":"24","author":"K Kapoor","year":"2014","unstructured":"Kapoor K, Jain S, Jajoo M, Dublish S, Dabas V, Manchanda V. Risk Factors and Predictors of Mortality in Critically ill Children with Extensively-Drug Resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit. Iran J Pediatr. 2014;24(5):569\u201374.","journal-title":"Iran J Pediatr"},{"issue":"6","key":"14128_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00005792-199511000-00004","volume":"74","author":"H Seifert","year":"1995","unstructured":"Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Med (Baltim). 1995;74(6):340\u20139. https:\/\/doi.org\/10.1097\/00005792-199511000-00004.","journal-title":"Med (Baltim)"},{"issue":"2","key":"14128_CR31","first-page":"119","volume":"31","author":"SY Lin","year":"1998","unstructured":"Lin SY, Wong WW, Fung CP, Liu CE, Liu CY. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases. J Microbiol Immunol Infect. 1998;31(2):119\u201324.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"14128_CR32","first-page":"127","volume":"38","author":"HP Chen","year":"2005","unstructured":"Chen HP, Chen TL, Lai CH, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect. 2005;38(2):127\u201336.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"14128_CR33","first-page":"63","volume":"24","author":"K Leepethacharat","year":"2007","unstructured":"Leepethacharat K, Oberdorfer P. Acinetobacter baumannii Infection and colonization among pediatric patients at Chiang Mai University Hospital. J Infect Dis Antimicrob Agents. 2007;24(2):63\u201373.","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"14128_CR34","doi-asserted-by":"publisher","unstructured":"Shi J, Sun T, Cui Y, et al. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis. 2020;12;20(1):597. https:\/\/doi.org\/10.1186\/s12879-020-05321-y.","DOI":"10.1186\/s12879-020-05321-y"},{"key":"14128_CR35","doi-asserted-by":"publisher","first-page":"1282413","DOI":"10.3389\/fpubh.2023.1282413","volume":"30","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu G, Miao F, Huang W, Wang H, Wang X. Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children. Front Public Health. 2023;30:11:1282413. https:\/\/doi.org\/10.3389\/fpubh.2023.1282413.","journal-title":"Front Public Health"},{"issue":"6","key":"14128_CR36","doi-asserted-by":"publisher","first-page":"e0072521","DOI":"10.1128\/mSphere.00725-21","volume":"22","author":"D Jalal","year":"2021","unstructured":"Jalal D, Elzayat MG, Diab AA, et al. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt. mSphere. 2021;22(6):e0072521. https:\/\/doi.org\/10.1128\/mSphere.00725-21.","journal-title":"mSphere"},{"issue":"7","key":"14128_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","volume":"20","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Tansarli GS, Karageorgopoulos DE, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170\u20135. https:\/\/doi.org\/10.3201\/eid2007.121004.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"14128_CR38","doi-asserted-by":"publisher","first-page":"001379","DOI":"10.12890\/2020_001379","volume":"7","author":"V Tosatto","year":"2020","unstructured":"Tosatto V, Cruz C, Ferreira T, et al. Recurrent Klebsiella pneumoniae Infection Causing Transcatheter Aortic Valve Implantation (TAVI)-Related Endocarditis. Eur J Case Rep Intern Med. 2020;7(3):001379. https:\/\/doi.org\/10.12890\/2020_001379.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"14128_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bj.2015.07.001","volume":"39","author":"CY Lin","year":"2016","unstructured":"Lin CY, Chen YM, Lin MC, et al. Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients. Biomed J. 2016;39(2):130\u20138. https:\/\/doi.org\/10.1016\/j.bj.2015.07.001.","journal-title":"Biomed J"},{"issue":"4","key":"14128_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/sur.2006.029","volume":"8","author":"V Trottier","year":"2007","unstructured":"Trottier V, Namias N, Pust DG, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt). 2007;8(4):437\u201343. https:\/\/doi.org\/10.1089\/sur.2006.029.","journal-title":"Surg Infect (Larchmt)"},{"issue":"12","key":"14128_CR41","doi-asserted-by":"publisher","first-page":"e52349","DOI":"10.1371\/journal.pone.0052349","volume":"7","author":"RK Shields","year":"2012","unstructured":"Shields RK, Clancy CJ, Gillis LM, et al. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS ONE. 2012;7(12):e52349. https:\/\/doi.org\/10.1371\/journal.pone.0052349.","journal-title":"PLoS ONE"},{"issue":"2","key":"14128_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.diagmicrobio.2010.12.023","volume":"70","author":"RK Shields","year":"2011","unstructured":"Shields RK, Kwak EJ, Potoski BA, et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011;70(2):246\u201352. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.023.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"14128_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jac\/dkm509","volume":"61","author":"M Bassetti","year":"2008","unstructured":"Bassetti M, Repetto E, Righi E, et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J Antimicrob Chemother. 2008;61(2):417\u201320. https:\/\/doi.org\/10.1093\/jac\/dkm509.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"14128_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jinf.2005.11.019","volume":"53","author":"S Motaouakkil","year":"2006","unstructured":"Motaouakkil S, Charra B, Hachimi A, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect. 2006;53(4):274\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2005.11.019.","journal-title":"J Infect"},{"issue":"12","key":"14128_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","volume":"12","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect. 2006;12(12):1227\u201330. https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01559.x.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"14128_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajic.2011.12.014","volume":"40","author":"K Ku","year":"2012","unstructured":"Ku K, Pogue JM, Moshos J, et al. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and\/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control. 2012;40(10):983\u20137. https:\/\/doi.org\/10.1016\/j.ajic.2011.12.014.","journal-title":"Am J Infect Control"},{"key":"14128_CR47","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2217\/fmb-2016-0036","volume":"11","author":"YT Huang","year":"2016","unstructured":"Huang YT, Liao CH, Teng LJ, Hsu HS, Hsueh PR. Reinfection and relapse of recurrent bacteremia caused by Klebsiella pneumoniae in a medical center in Taiwan. Future Microbiol. 2016;11:1157\u201365. https:\/\/doi.org\/10.2217\/fmb-2016-0036.","journal-title":"Future Microbiol"},{"issue":"10","key":"14128_CR48","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10096-017-3020-x","volume":"36","author":"M Giannella","year":"2017","unstructured":"Giannella M, Graziano E, Marconi L, et al. Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36(10):1965\u201370. https:\/\/doi.org\/10.1007\/s10096-017-3020-x.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14128-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:38:59Z","timestamp":1790260739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14128"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14128-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Dokuz Eyl\u00fcl University (protocol number: 2023\/31-17). Due to the retrospective design, the requirement for informed consent was waived. All procedures were conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1718"}}